If you haven't seen the latest Java developer productivity report from Perforce, you should check it out. Written by Perforce CTO Rod Cope and developer tools exec Jeff Michael, the "2025 Java ...
Officials in Belchertown, Mass., were saving up to fix their broken roads and aging buildings last year when they were hit with a surprise $911,000 invoice. The bill came from the Hampshire County ...
Eli Lilly said its next-generation drug cleared a crucial late-stage trial in patients with obesity, delivering significant weight loss across doses. The results bring Lilly one step closer to filing ...
People who got the injection, retatrutide, lost 28 percent of their body weight on average after 80 weeks, Eli Lilly said. By Gina Kolata and Rebecca Robbins An experimental shot helped participants ...
The importance of strength training is well known. But when it comes to how to strength train, the advice can be confusing. Popular workout modalities take vastly different approaches. Low-impact ...
Novo Nordisk sees a "major opportunity" outside of the U.S. and says that telehealth partners could help grow the global market for weight loss drugs. The battle for dominance over the lucrative ...
Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...
WASHINGTON – President Donald Trump's annual medical exam showed he's in "excellent health" – though his doctor recommended he exercise more and lower the regular aspirin dose that has contributed to ...
NEW YORK, May 21 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Thursday its experimental obesity drug helped patients lose more ‌than 28% of their weight over a year and a half in a key trial ...
GLP-1 medications, such as those with semaglutide, may help you lose weight that’s gained during perimenopause or menopause. They may have an enhanced effect when combined with menopausal hormone ...
(NewsNation) — A new experimental weight loss drug that targets three hormones simultaneously may outperform Ozempic and Mounjaro, but patients need close medical supervision to use it safely, a ...
National security, unlocked. Each Thursday, host Mary Louise Kelly and a team of NPR correspondents discuss the biggest national security news of the week. With decades of reporting from battlefields ...